155 related articles for article (PubMed ID: 7700691)
1. [Effect of anapriline on the pharmacodynamic effects of strophanthin in experiments on isolated myocardial preparations and under conditions of simulation of cardiac insufficiency].
Lemkina SM
Patol Fiziol Eksp Ter; 1994; (4):16-8. PubMed ID: 7700691
[TBL] [Abstract][Full Text] [Related]
2. [The influence of kordaron on the pharmacodynamic effects of strophanthin in experiments on isolated myocardial preparations and in the modelling of heart failure].
Lemkina SM
Eksp Klin Farmakol; 1993; 56(4):30-3. PubMed ID: 8220011
[TBL] [Abstract][Full Text] [Related]
3. [Effect of isoptin on toxic and cardiotonic effect of strophanthin K].
Lemkina SM
Kardiologiia; 1993; 33(5):37-40. PubMed ID: 7967327
[TBL] [Abstract][Full Text] [Related]
4. [Changes in the chrono-inotropic properties of the myocardium and oxygen consumption as affected by strophanthin-K, isoptin and their combination].
Lemkina SM
Patol Fiziol Eksp Ter; 1994; (3):26-8. PubMed ID: 7824338
[TBL] [Abstract][Full Text] [Related]
5. Effects of long-term treatment with trandolapril on sarcoplasmic reticulum function of cardiac muscle in rats with chronic heart failure following myocardial infarction.
Yamaguchi F; Sanbe A; Takeo S
Br J Pharmacol; 1998 Jan; 123(2):326-34. PubMed ID: 9489622
[TBL] [Abstract][Full Text] [Related]
6. Improvement of cardiac function and myocardial energy metabolism of rats with chronic heart failure by long-term coenzyme Q10 treatment.
Sanbe A; Tanonaka K; Niwano Y; Takeo S
J Pharmacol Exp Ther; 1994 Apr; 269(1):51-6. PubMed ID: 8169851
[TBL] [Abstract][Full Text] [Related]
7. [The effect of the glycoside strophanthin K on the ultrastructure of the cardiomyocytes in the pro-oxidant zone of the myocardium in rats with experimental heart failure].
Chernysh IN; Sadovnikov VB
Eksp Klin Farmakol; 1997; 60(4):29-31. PubMed ID: 9376752
[TBL] [Abstract][Full Text] [Related]
8. [Influence of kordaron, anaprilin, dimedrol and riboxin on the hemodynamic effects of strophanthin in experimental heart failure].
Gendenshteĭn EI; Lemkina SM
Farmakol Toksikol; 1988; 51(2):53-6. PubMed ID: 3378606
[TBL] [Abstract][Full Text] [Related]
9. [Myocardial contractile function in acute heart failure during exposure to strophanthin and its combination with alpha-tocopherol].
Chekman IS; Frantsuzova SB; Antonenko LI; Gudivok IaS
Farmakol Toksikol; 1988; 51(4):44-7. PubMed ID: 3191972
[TBL] [Abstract][Full Text] [Related]
10. [The effect of nitroglycerin on the pharmacological properties of strophanthin in experiments in vitro and in vivo].
Sergeev PV; Galenko-Iaroshevskiĭ PA; Lemkina SM; Kostin IaV
Biull Eksp Biol Med; 1995 Apr; 119(4):387-90. PubMed ID: 7620136
[No Abstract] [Full Text] [Related]
11. Mechanisms of preserved baseline cardiac systolic function in rats with adrenergic inotropic downregulation.
Osadchii O; Woodiwiss A; Alves N; Norton G
Life Sci; 2005 Dec; 78(4):366-75. PubMed ID: 16137710
[TBL] [Abstract][Full Text] [Related]
12. [After-contractions as a cause of late diastolic "tonus increase" of the heart. Studies of diastolic extensibility of the isolated frog heart under propranolol, hexobarbital and k-strophanthin].
Kissling G; Segarra-Domenech J; Jacob R
Z Kreislaufforsch; 1969 Jan; 58(1):34-43. PubMed ID: 5791450
[No Abstract] [Full Text] [Related]
13. [Cardiotoxicity of strophanthin for rats and its correction with anaprilin in coronary-related and non-coronary-related damage to the myocardium and acute cardiac insufficiency].
Gendenshteĭn ZI; Lemkina SM
Biull Eksp Biol Med; 1984 Jun; 97(6):683-6. PubMed ID: 6743806
[TBL] [Abstract][Full Text] [Related]
14. [Effect of ether-oxygen anesthesia and of the premedication agents on the toxicity and cardiotonic effect of strophanthin].
Gatsura VV; Mitchenko PP
Farmakol Toksikol; 1975; 38(5):568-71. PubMed ID: 1183587
[TBL] [Abstract][Full Text] [Related]
15. Pitavastatin improves cardiac function and survival in association with suppression of the myocardial endothelin system in a rat model of hypertensive heart failure.
Saka M; Obata K; Ichihara S; Cheng XW; Kimata H; Nishizawa T; Noda A; Izawa H; Nagata K; Murohara T; Yokota M
J Cardiovasc Pharmacol; 2006 Jun; 47(6):770-9. PubMed ID: 16810078
[TBL] [Abstract][Full Text] [Related]
16. [Effect of the membrane stabilizer ajmaline and the local anesthetic trimecaine on the pharmacologic effects of strophanthin in experiments in vivo and in vitro].
Galenko-Iaroshevskiĭ PA; Lemkina SM; Kostin IaV
Biull Eksp Biol Med; 1994 Jan; 117(1):59-61. PubMed ID: 8193333
[No Abstract] [Full Text] [Related]
17. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of diabetic rats. Part B.
Wiśniewska RJ
Pol J Pharmacol; 1998; 50(3):213-23. PubMed ID: 9861629
[TBL] [Abstract][Full Text] [Related]
18. [Effect of cardiac desympathization, stimulation of the central adrenergic structures and blockade of beta-adrenergic receptors on cardiotonic and cardiotoxic effect of cardiac glycosides].
Smolenskiĭ VS; Abinder AA; Khitrov NK; Kamenker SM
Kardiologiia; 1977 Sep; 17(9):60-70. PubMed ID: 926604
[TBL] [Abstract][Full Text] [Related]
19. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
Wiśniewska RJ
Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
[TBL] [Abstract][Full Text] [Related]
20. The sympathoadrenal system mediates the blood pressure and cardiac effects of human coagulation factor XII-related "new pressor protein".
Mavrogiannis L; Trambakoulos DM; Boomsma F; Osmond DH
Can J Cardiol; 2002 Oct; 18(10):1077-86. PubMed ID: 12420043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
